MindBio Therapeutics has an EPS of $-0.038922. In 2022, the company made an earnings per share (EPS) of $-0.056183. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$0.038922 | -30.72% |
2022 | -$0.056183 | - |